Should consolidation autologous stem cell transplant be considered for de novo follicular lymphoma transformation to DLBCL after achieving a PR with R-CHOP x 6 cycles, if residual disease showed original indolent follicular lymphoma?
Answer from: Medical Oncologist at Academic Institution
First, it is important to make sure that residual disease is FL rather than tFL, which it sounds like you have already done. However, the PET scan should be reviewed; if there is a different node that has very high FDG uptake, then that node should be sampled to rule out residual DLBCL.
...
Comments
Medical Oncologist at Siri Onclogy and hematology Infusion Service All the above is correct, but the one thing concer...
All the above is correct, but the one thing concer...